Collegium Pharmaceutical

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.

CEO

Vikram Karnani

CEOVikram Karnani

Employees

357

Employees357

Headquarters

Stoughton, Massachusetts

HeadquartersStoughton, Massachusetts

Founded

2002

Founded2002

Employees

357

Employees357

COLL Key Statistics

Market cap

974.87M

Market cap974.87M

Price-Earnings ratio

25.01

Price-Earnings ratio25.01

Dividend yield

—

Dividend yield—

Average volume

291.32K

Average volume291.32K

High today

$30.92

High today$30.92

Low today

$29.82

Low today$29.82

Open price

$30.50

Open price$30.50

Volume

140.31K

Volume140.31K

52 Week high

$42.29

52 Week high$42.29

52 Week low

$23.23

52 Week low$23.23

People also own

Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.